Esophagus to Small Intestine

Endoscopy. 2023;55(10):918–26

Lacroute J, Marcantoni J, Petitot S, Weber J, Levy P, Dirrenberger B, Tchoumak I, Baron M, Gibert S, Marguerite S, Huppertz J, Gronier O, Derlon A

The carbon footprint of ambulatory gastrointestinal endoscopy


Background: Endoscopy is considered the third highest generator of waste within healthcare. This is of public importance as approximately 18 million endoscopy procedures are performed yearly in the United States and 2 million in France. However, a precise measure of the carbon footprint of gastrointestinal endoscopy (GIE) is lacking.
Methods: This retrospective study for 2021 was conducted in an ambulatory GIE center in France where 8524 procedures were performed on 6070 patients. The annual carbon footprint of GIE was calculated using “Bilan Carbone” of the French Environment and Energy Management Agency. This multicriteria method accounts for direct and indirect greenhouse gas (GHG) emissions from energy consumption (gas and electricity), medical gases, medical and non-medical equipment, consumables, freight, travel, and waste.
Results: GHG emissions in 2021 were estimated to be 241.4 tons CO2 equivalent (CO2e) at the center, giving a carbon footprint for 1 GIE procedure of 28.4 kg CO2e. The main GHG emission, 45% of total emissions, was from travel by patients and center staff to and from the center. Other emission sources, in rank order, were medical and non-medical equipment (32%), energy consumption (12%), consumables (7%), waste (3%), freight (0.4%), and medical gases (0.005%).

Conclusions: This is the first multicriteria analysis assessing the carbon footprint of gastrointestinal endoscopy (GIE). It highlights that travel, medical equipment, and energy are major sources of impact, with waste being a minor contributor. This study provides an opportunity to raise awareness among gastroenterologists of the carbon footprint of GIE procedures.

Dr. J. Lacroute, Department of Gastroenterology, Centre d’Endoscopie et de Médecine Ambulatoire, Strasbourg, France, E-Mail: joel.lacroute@yahoo.fr

DOI: 10.1055/a-2088-4062

Back to overview

this could be of interest:

Persistent villous atrophy predicts development of complications and mortality in adult patients with celiac disease: A multicenter longitudinal cohort study and development of a score to identify high-risk patients

Gut. 2023;72(11):2095–102

Early ileocecal resection for Crohn’s disease is associated with improved long-term outcomes compared with anti-tumor necrosis factor therapy: A population-based cohort study

Gastroenterology. 2023;165(4):976–85.e3

More articles on the topic